Hikma Pharmaceuticals PLC (HIK) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.063x

Based on the latest financial reports, Hikma Pharmaceuticals PLC (HIK) has a cash flow conversion efficiency ratio of 0.063x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX161.00 Million ≈ $19.59K USD) by net assets (GBX2.55 Billion ≈ $310.38K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HIK cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Hikma Pharmaceuticals PLC - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Hikma Pharmaceuticals PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hikma Pharmaceuticals PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hikma Pharmaceuticals PLC ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
BJC Heavy Industries Public Company Limited BK:BJCHI	0.054x
Nuintek Co.Ltd KQ:012340	0.128x
BG Staffing Inc NYSE:BGSF	0.042x
Swiss Water Decaffeinated Coffee Inc TO:SWP	0.092x
Fiyta Holdings Ltd SHE:200026	0.040x
SCI Information Service Inc KQ:036120	0.049x
KebNi AB (publ) ST:KEBNI-B	0.158x
Total Soft Bank Ltd KQ:045340	0.094x

Annual Cash Flow Conversion Efficiency for Hikma Pharmaceuticals PLC (2002–2024)

The table below shows the annual cash flow conversion efficiency of Hikma Pharmaceuticals PLC from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see Hikma Pharmaceuticals PLC stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	GBX2.32 Billion ≈ $282.40K	GBX564.00 Million ≈ $68.62K	0.243x	-11.71%
2023-12-31	GBX2.21 Billion ≈ $268.77K	GBX608.00 Million ≈ $73.98K	0.275x	+11.55%
2022-12-31	GBX2.15 Billion ≈ $261.35K	GBX530.00 Million ≈ $64.49K	0.247x	-4.59%
2021-12-31	GBX2.47 Billion ≈ $300.16K	GBX638.00 Million ≈ $77.63K	0.259x	+19.72%
2020-12-31	GBX2.15 Billion ≈ $261.35K	GBX464.00 Million ≈ $56.46K	0.216x	-2.56%
2019-12-31	GBX2.13 Billion ≈ $259.04K	GBX472.00 Million ≈ $57.43K	0.222x	-12.51%
2018-12-31	GBX1.70 Billion ≈ $206.48K	GBX430.00 Million ≈ $52.32K	0.253x	-12.60%
2017-12-31	GBX1.53 Billion ≈ $185.91K	GBX443.00 Million ≈ $53.90K	0.290x	+138.57%
2016-12-31	GBX2.41 Billion ≈ $293.35K	GBX293.00 Million ≈ $35.65K	0.122x	-55.11%
2015-12-31	GBX1.35 Billion ≈ $164.50K	GBX366.00 Million ≈ $44.53K	0.271x	-22.55%
2014-12-31	GBX1.22 Billion ≈ $147.95K	GBX425.00 Million ≈ $51.71K	0.350x	+7.24%
2013-12-31	GBX1.03 Billion ≈ $125.81K	GBX337.00 Million ≈ $41.00K	0.326x	+51.70%
2012-12-31	GBX847.85 Million ≈ $103.16K	GBX182.16 Million ≈ $22.16K	0.215x	+67.18%
2011-12-31	GBX798.63 Million ≈ $97.17K	GBX102.64 Million ≈ $12.49K	0.129x	-30.52%
2010-12-31	GBX750.30 Million ≈ $91.29K	GBX138.79 Million ≈ $16.89K	0.185x	+19.78%
2009-12-31	GBX683.26 Million ≈ $83.13K	GBX105.52 Million ≈ $12.84K	0.154x	+62.51%
2008-12-31	GBX609.00 Million ≈ $74.10K	GBX57.87 Million ≈ $7.04K	0.095x	-6.41%
2007-12-31	GBX424.66 Million ≈ $51.67K	GBX43.12 Million ≈ $5.25K	0.102x	+18.42%
2006-12-31	GBX349.80 Million ≈ $42.56K	GBX29.99 Million ≈ $3.65K	0.086x	-24.65%
2005-12-31	GBX287.48 Million ≈ $34.98K	GBX32.71 Million ≈ $3.98K	0.114x	-49.70%
2004-12-31	GBX145.18 Million ≈ $17.66K	GBX32.84 Million ≈ $4.00K	0.226x	-25.43%
2003-12-31	GBX60.47 Million ≈ $7.36K	GBX18.35 Million ≈ $2.23K	0.303x	+1.52%
2002-12-31	GBX48.03 Million ≈ $5.84K	GBX14.35 Million ≈ $1.75K	0.299x	--

About Hikma Pharmaceuticals PLC

LSE:HIK UK Drug Manufacturers - Specialty & Generic

Market Cap

$39.53 Million

GBX324.87 Billion GBX

Market Cap Rank

#22821 Global

#184 in UK

Share Price

GBX1467.00

Change (1 day)

+0.00%

52-Week Range

GBX1191.00 - GBX2070.00

All Time High

GBX2408.28